天大藥業(00455.HK)擬2500萬港元收購瑤池漢方醫療50.1%股權
格隆匯10月5日丨天大藥業(00455.HK)發佈公告,於2020年10月5日,買方天大館(香港)有限公司(公司全資附屬公司)與賣方楊明霞博士訂立股權轉讓及合作協議,據此買方已有條件同意以2500萬港元的現金代價收購目標公司瑤池漢方醫療中心有限公司已發行股份的50.1%。
於簽訂股權轉讓及合作協議前,賣方及物業擁有人訂立物業收購協議,據此,物業擁有人以代價6000萬港元向目標公司轉讓物業公司金舵有限公司全部已發行股份。由於物業公司將成為目標公司的附屬公司,集團(通過天大館集團)及賣方已於交割時按彼等各自於目標公司的持股比例就物業收購協議項下的代價以銀行轉賬方式分別向目標公司作出3006萬港元及2994萬港元的預付款項。
於本公告日期,物業公司已成為目標公司的附屬公司。該物業為位於香港恩平道48號恩平中心21樓1、2及3號辦公室,總建築面積約為2,713平方尺。
目標公司為香港一間中醫醫療機構,主要業務為以傳統中醫理論及實證科學為基礎,融入先進的醫療科技與設備,提供高端而現代化的中醫醫療服務,包括中醫診症、鍼灸、拔罐、推拿、皮膚及體質健康檢查等健康管理服務。於本公告日期,瑤池養生是一間於香港註冊成立的公司,註冊資本為10,000港元,分為10,000股股份,其中6,000股由目標公司擁有及4,000股由賣方擁有。瑤池養生的主要業務為在香港從事經營中藥保健品的銷售業務。
進行收購事項的理由及裨益:提升天大館業務和營運效率,助力天大館在粵港澳大灣區發展;擴大服務組合和消費者基礎;改善集團的財務表現及提升市值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.